Lazard Asset Management LLC Agios Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $136 - $238	7 Added 0.23%	3,061 $86,000
Q2 2022 Aug 09, 2022	BUY	$17.06 - $31.42 $2,115 - $3,896	124 Added 4.23%	3,054 $67,000
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $21,477 - $28,022	805 Added 37.88%	2,930 $84,000
Q4 2021 Feb 09, 2022	BUY	$29.58 - $49.78 $354 - $597	12 Added 0.57%	2,125 $69,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $21,672 - $30,079	-517 Reduced 19.66%	2,113 $97,000
Q2 2021 Aug 12, 2021	BUY	$52.06 - $61.27 $134,314 - $158,076	2,580 Added 5160.0%	2,630 $144,000
Q4 2020 Feb 11, 2021	BUY	$33.21 - $46.54 $1,660 - $2,327	50 New	50 $2,000
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $79,289 - $130,932	-2,341 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$34.45 - $53.48 $9,060 - $14,065	263 Added 12.66%	2,341 $125,000
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $65,498 - $111,817	2,078 New	2,078 $73,000
Q1 2019 May 13, 2019	SELL	$45.92 - $67.67 $656,656 - $967,681	-14,300 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $2.49 Million - $3.2 Million	-34,787 Reduced 70.87%	14,300 $1.1 Million
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $1.51 Million - $2.05 Million	20,555 Added 72.04%	49,087 $4.13 Million
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $634,437 - $917,564	-10,604 Reduced 27.1%	28,532 $2.33 Million
Q4 2017 Feb 13, 2018	SELL	$52.12 - $72.33 $704,818 - $978,118	-13,523 Reduced 25.68%	39,136 $2.24 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $1.27 Million - $1.56 Million	23,179 Added 78.63%	52,659 $3.51 Million
Q2 2017 Aug 19, 2019	BUY	N/A	29,480	29,480 $1.52 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.6 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account